Skip to main content

Table 3 Characteristics of the study participants at baseline and follow-up (n = 235)

From: Risk factors for electrocardiographic left ventricular hypertrophy in a young Chinese general population: the Hanzhong adolescent cohort study

Variable

Baseline in 2013

Follow-up in 2017

P values

Female, no. (%)

104 (44.2)

104 (44.2)

–

Age, years

39 (36, 41)

43 (40, 45)

 < 0.001

Current smoking, no. (%)

110 (41.5)

105 (44.6)

0.489

Alcohol use, no. (%)

23 (9.1)

65 (27.8)

 < 0.001

BMI, Kg/m2

23.83 (21.63–26.33)

23.73 (22.19–25.92)

0.826

WHR

0.90 (0.85–0.95)

0.93 (0.87–0.97)

 < 0.001

Hypertension, no. (%)

79 (29.7)

53 (22.6)

0.792

Diabetes mellitus, no. (%)

6 (2.3)

15 (6.2)

0.023

SBP, mmHg

120.7 (111.3–132.0)

121.0 (112.8–131.7)

0.403

DBP, mmHg

80.0 (72.7–89.0)

76.3 (69.3–84.8)

0.001

Heart rate, beats/min

70.0 (66.0–80.0)

74.0 (67.0–81.0)

0.022

SUA, μmol/L

300.9 (246.0–369.7)

267.9 (209.7–335.8)

 < 0.001

Serum creatinine, umol/L

74.21 ± 14.02

80.82 ± 17.69

 < 0.001

eGFR, mL/min/1.73m2

94.90 ± 21.13

94.12 ± 26.23

0.694

Fasting glucose, mmol/L

4.58 (4.26–4.92)

5.00 (4.69–5.41)

 < 0.001

Total cholesterol, mmol/L

4.27 (3.83–4.72)

4.51 (4.07–4.99)

 < 0.001

Triglycerides, mmol/L

1.42 (1.00–2.07)

1.37 (0.98–1.96)

0.405

LDL-C, mmol/L

2.33 (2.00–2.70)

2.51 (2.14–2.89)

0.001

HDL-C, mmol/L

1.66 (1.43–1.87)

1.14 (1.01–1.32)

 < 0.001

UACR, mg/g

6.07 (4.08–10.72)

8.80 (5.77–15.17)

 < 0.001

CIMT, mm

0.50 (0.40–0.60)

0.64 (0.55–0.74)

 < 0.001

LVH, no. (%)

–

26 (11.0)

–

  1. BMI body mass index, WHR waist hip rate, SBP systolic blood pressure, DBP diastolic blood pressure, SUA serum uric acid, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein, uACR Urinary albumin-to-creatinine ratio, CIMT carotid intima-media thickness